Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aminoacylindazole immunomodulators for treatment of autoimmune diseases

Aminoacylindazole immunomodulators for treatment of autoimmune diseases

US Patent 10538512 · Granted Jan 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcho2024
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcho2022
Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune2022
Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune2022
Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune2022
Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune2022
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcho2021
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcho2021
Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses 2021
Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles2018
Glycosidase inhibitors and uses thereof2018
Pyrimidone carboxamide compounds as PDE2 inhibitors2017